![PRD_002359 PRD_002359](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002359.svg) | PRD_002359 | Name: | OO1-WFP-SER-PRO-YCP-ALA-MP8 ureadepsipeptide | Formula: | C40 H49 F2 N7 O8 | Definition date: | 2019-11-06 | Last modified: | 2019-11-06 |
|
![PRD_002368 PRD_002368](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002368.svg) | PRD_002368 | Name: | cyclo-Mle-Phe-Mle-D-Phe. D-Phe analogue of pseudoxylallemycin A | Formula: | C32 H44 N4 O4 | Definition date: | 2019-10-02 | Last modified: | 2019-10-02 |
|
![PRD_002333 PRD_002333](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002333.svg) | PRD_002333 | Name: | Pseudoxylallemycin A | Formula: | C32 H44 N4 O4 | Definition date: | 2019-09-11 | Last modified: | 2019-09-11 |
|
![PRD_002334 PRD_002334](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002334.svg) | PRD_002334 | Name: | Linear tetrapeptide related to pseudoxylallemycin A | Formula: | C32 H46 N4 O5 | Definition date: | 2019-09-11 | Last modified: | 2019-09-11 |
|
![PRD_002335 PRD_002335](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002335.svg) | PRD_002335 | Name: | Linear precursor of pseudoxylallemycin A | Formula: | C32 H46 N4 O5 | Description: | Mle-Phe-Mle-Phe. Linear precursor of pseudoxylallemycin A. The peptide is linear, unlike Mle-Phe-Mle-Phe Pseudoxylallemycin A that is cyclic. | Definition date: | 2019-09-11 | Last modified: | 2019-09-11 |
|
![PRD_002355 PRD_002355](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002355.svg) | PRD_002355 | Name: | Microcin C | Formula: | C38 H63 N17 O17 P S | Definition date: | 2019-07-10 | Last modified: | 2019-07-10 |
|
![PRD_002306 PRD_002306](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002306.svg) | PRD_002306 | Name: | (2S,5R,8S,11S,14R,17S,20S,22R,23S)-5-[(2E)-but-2-en-1-yl]-23-hydroxy-8-({1-[(3R)-3-hydroxy-2-methylbutan-2-yl]-1H-indol-3-yl}methyl)-14-[(4-hydroxy-3-nitrophenyl)methyl]-10,17,19,22-tetramethyl-2,11-bis(2-methylpropyl)-1,4,7,10,13,16,19-heptaazabicyclo[18.3.1]tetracosane-3,6,9,12,15,18,24-heptone | Formula: | C54 H77 N9 O12 | Definition date: | 2019-06-04 | Last modified: | 2019-06-04 |
|
![PRD_002311 PRD_002311](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002311.svg) | PRD_002311 | Name: | ACE-MVA-MP8-NZC-LEU-MP8-LEU-MVA-PRO-MLU-GLY | Formula: | C57 H96 N10 O12 | Definition date: | 2019-05-29 | Last modified: | 2019-05-29 |
|
![PRD_002312 PRD_002312](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002312.svg) | PRD_002312 | Name: | (GZJ)VDINNN(CY3) Cyclic peptide inhibitor | Formula: | C36 H58 N12 O14 S | Definition date: | 2019-04-17 | Last modified: | 2019-04-17 |
|
![PRD_002313 PRD_002313](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002313.svg) | PRD_002313 | Name: | WDINNN(BAL) Cyclic peptide inhibitor | Formula: | C36 H49 N11 O12 | Definition date: | 2019-04-17 | Last modified: | 2019-04-17 |
|
![PRD_002319 PRD_002319](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002319.svg) | PRD_002319 | Name: | (6D6)PPKRIA(NH2), DC100-1 | Formula: | C48 H84 N18 O11 | Definition date: | 2019-04-03 | Last modified: | 2019-04-03 |
|
![PRD_002316 PRD_002316](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002316.svg) | PRD_002316 | Name: | Apollo peptide | Formula: | C46 H68 N8 O7 | Definition date: | 2019-02-13 | Last modified: | 2019-02-13 |
|
![PRD_002284 PRD_002284](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002284.svg) | PRD_002284 | Formula: | C37 H57 N11 O11 | Definition date: | 2018-11-07 | Last modified: | 2018-11-07 |
|
![PRD_002328 PRD_002328](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002328.svg) | PRD_002328 | Name: | TYROSTATIN (Bound Form) | Formula: | C29 H41 N3 O6 | Definition date: | 2018-10-24 | Last modified: | 2018-10-31 |
|
![PRD_002327 PRD_002327](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002327.svg) | PRD_002327 | Name: | PSEUDOTYROSTATIN (Bound Form) | Formula: | C23 H30 N2 O5 | Definition date: | 2018-10-24 | Last modified: | 2018-10-24 |
|
![PRD_002331 PRD_002331](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002331.svg) | PRD_002331 | Name: | Chymostatin A (bound form) | Formula: | C31 H43 N7 O6 | Definition date: | 2018-10-24 | Last modified: | 2018-10-24 |
|
![PRD_002298 PRD_002298](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002298.svg) | PRD_002298 | Name: | N2-[4-(carbamimidamidomethyl)phenyl]acetyl-D-lysyl-L-lysyl-D-arginine | Formula: | C28 H51 N11 O5 | Definition date: | 2018-10-17 | Last modified: | 2018-10-17 |
|
![PRD_002304 PRD_002304](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002304.svg) | PRD_002304 | Name: | N2-{[4-(carbamimidamidomethyl)phenyl]acetyl}-L-arginyl-L-arginyl-N-[(4-carbamimidoylphenyl)methyl]-L-argininamide | Formula: | C36 H61 N18 O4 | Definition date: | 2018-10-17 | Last modified: | 2018-10-17 |
|
![PRD_002309 PRD_002309](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002309.svg) | PRD_002309 | Name: | N2-(phenylacetyl)-D-lysyl-D-lysyl-D-arginine | Formula: | C26 H45 N8 O5 | Definition date: | 2018-10-17 | Last modified: | 2018-10-17 |
|
![PRD_002317 PRD_002317](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002317.svg) | PRD_002317 | Name: | N-Me-p-iodo-D-Phe1,N-Me-D-Gln4,Lys10-teixobactin analogue | Formula: | C59 H99 I N13 O15 | Definition date: | 2018-10-17 | Last modified: | 2018-10-17 |
|
![PRD_002307 PRD_002307](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002307.svg) | PRD_002307 | Name: | Phalloidin | Formula: | C35 H48 N8 O11 S | Definition date: | 2018-09-19 | Last modified: | 2018-09-19 |
|
![PRD_002323 PRD_002323](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002323.svg) | PRD_002323 | Name: | N-METHYL-4-HYDROXY-LEUCINE CYCLOSPORIN | Formula: | C62 H111 N11 O13 | Definition date: | 2018-09-12 | Last modified: | 2018-09-12 |
|
![PRD_002324 PRD_002324](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002324.svg) | PRD_002324 | Name: | [D-(CHOLINYLESTER)SER8]-CYCLOSPORIN | Formula: | C62 H111 N11 O13 | Definition date: | 2018-09-12 | Last modified: | 2018-09-12 |
|
![PRD_002318 PRD_002318](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002318.svg) | PRD_002318 | Name: | SRC2-BCP1 | Formula: | C64 H109 N19 O15 | Definition date: | 2018-07-25 | Last modified: | 2018-07-25 |
|
![PRD_002227 PRD_002227](https://data.pdbj.org/pdbjplus/data/cc/svg/7YF.svg) | PRD_002227 | Name: | (2R)-N-[2-[[(2S)-5-carbamimidamido-1-oxidanylidene-pentan-2-yl]amino]-2-oxidanylidene-ethyl]-5-oxidanylidene-1,2-dihydropyrrole-2-carboxamide | Formula: | C13 H20 N6 O4 | Definition date: | 2018-07-11 | Last modified: | 2018-07-11 |
|